Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Abnormal metabolism in type 2 diabetes, and how this affects the heart

None

The study of metabolism has a strong historical basis in Oxford, and in the last 20 years research in this field has undergone a renaissance. Abnormalities in cardiac metabolism have been identified in many pathologies, and have been shown to directly impair the function of the heart, accelerate disease progression and to predict mortality. Given the pivotal role of metabolism in keeping the heart contracting, a greater understanding of what metabolism can do, how this is modified in disease and whether this information can be used to develop new treatments may lead to new therapies for the heart.

Type 2 diabetes is a systemic disease of abnormal metabolism, yet the primary cause of mortality in type 2 diabetes is cardiovascular disease.  Important questions remain as to what abnormal cardiac metabolism is doing to the heart in diabetes, and how it is having its effect.  We are studying metabolism from 2 angles in diabetes: as a source of energy to power the heart, but also as signalling molecules that can regulate transcription, post-translational modification, and enzyme activity.  Our aim is to understand how abnormal metabolism and metabolite levels are exerting their effect on the heart in diabetes.  We are particularly interested in the roles played by fats and lipids within the heart, and how these may be driving the metabolic and contractile dysfunction in diabetes.  Given the increasing prevalence of diabetes and metabolic syndrome in society, a greater understanding of how diabetes specifically affects the heart, and whether this can be rectified by therapy are important questions.

Our research can be divided into four key questions:

1. How is cardiac metabolism modified in type 2 diabetes?

2. What is this abnormal metabolism doing to the heart – are metabolites acting as signalling molecules?

3. What are the mechanisms regulating changes in cardiac metabolism?

4. Can these mechanisms be targeted by new pharmacological therapies to treat the heart?

Our team

John Fell Fund.pngCancer Research UK.pngNovoNordisk.pngBHF logo horizontalDiabetes UK

Our Achievements

DPAG members shine at the Oxford BHF CRE Annual Symposium 2019

Congratulations are in order to Matthew Kerr, Andia Redpath, Susann Bruche, KC Park and Minahil Mujahid for their achievements at this major showcase for Oxford's British Heart Foundation funded Researchers.

Three DPAG Academics recognised with Teaching Excellence Awards

The Medical Sciences Teaching Excellence Awards scheme recognises and rewards excellence in teaching, supervision, the organisation and development of teaching, and support for teaching and learning, within a research-intensive environment.

Matthew Kerr to receive the William C Stanley Early Investigator Award

Congratulations are in order for DPhil student Matthew Kerr, who has been awarded the William C Stanley Early Investigator Award. The award highlights the scientific accomplishments of promising young researchers and is a major focus of the Annual Meeting of the Society for Heart and Vascular Metabolism.

Related research themes